The Food and Drug Administration’s final guidance on opioid abuse seeks to help device developers in tackling an ongoing national crisis.
The final document, “Clinical Considerations for Studies of Devices Intended to Treat Opioid Use Disorder,” provides recommendations for the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?